AN2 Therapeutics to Participate at Upcoming Investor Conferences
October 20, 2026 · 4:13 PM · MENLO PARK, Calif.
AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced company management will participate in three upcoming investor conferences in November. Details of the events are as follows: Guggenheim 3rd Annual Healthcare Innovation Conference, November 9-11, 2026 Eric Easom, Co-Founder, Chairman, President and CEO, will...
- PublishedOctober 20, 2026 · 4:13 PM
- LocationMENLO PARK, Calif.
- IndustryScience
- LanguageEN
Published by Business Wire. Read the original announcement for the full release.
Read the full announcement →